baber/WOPTO huggingface dataset:
Patent JP-S5435652-B2 (JP)
IPC: E01H5/06
Filed: 1974-10-28
Abstract: Primary cell, in which the positive active material is silver chromate and in which the electrolyte may be constituted by a lithium perchlorate solution in propylene carbonate. According to the invention silver powder is added to the silver chromate in a proportion comprised between 5% and 30% by weight. A primary cell thus obtained may be used in an environment having a high temperature, such as an electrical device whose components heat up without any possibility of cooling.
Patent JP-3351814-B2 (JP)
IPC: A01N47/30
Filed: 1992-05-15
Granted: 2002-12-03
Abstract: The invention relates to storage-stable aqueous suspoemulsions which contain fenoxaprop-ethyl, a sulphonylurea and/or phenylurea, an aromatic solvent and a surfactant combination of ethoxylated tristyrylphenol and ethoxylated synthesis alcohol, which are optionally phosphated, to processes for their preparation, and to their use in crop protection.
Patent JP-H07101031-B2 (JP)
IPC: F04B9/12
Filed: 1990-05-17
Abstract: There is a lubricant pump having a compressed air piston motor in which a control device has a slide 14 which can move under the influence of a spring 29. In this case it is desirable if the spring device is separated from the compressed air flow, subject to the avoidance of remote control and hairpin springs. This is achieved in that the slide is an axially displaceable piston slide 14, in that a radially acting spring catch 17 is provided, having two latching slots 16, separated from one another in the axial direction, in that the piston rod 7 carries a helical compression spring 29 in a recess of the piston slide 14 and in that the piston rod 7 can be moved by the force of the compressed helical compression spring 29, subject to compression of the helical compression spring 29 and on overcoming the spring catch 17, 16 by means of a control stop 33. In this lubricant pump, the helical compression spring is arranged between the piston rod and the slide. 
<IMAGE>
Patent JP-3860642-B2 (JP)
IPC: C08G18/75
Filed: 1997-05-13
Granted: 2006-12-20
Abstract: Aqueous polyurethane coatings - contain a binder comprising (a) water-soluble or dispersible polyol component, (b) water-soluble or dispersible polyisocyanate component with capped isocyanate groups and (c) optional standard auxiliary agents and additives. The ratio of capped isocyanate groups in (b) to hydroxyl groups in (a) is at least 0.8:1.Component (a) comprises the following : (A1) 20-60 wt.% polyisocyanate comprising at least 50 wt.% 4,4`-diisocyanatodicyclohexyl methane and the rest other organic polyisocyanates with molecular weights of 140-1500 ; (B1) 20-65 wt.% one or more polyether polyols with hydroxy values of 25-350 mg KOH/g substance ; (C1) 2-12 wt.% (potential) anionic chain extender comprising at least one compound containing one or more groups which can react with NCO groups and at least one group which may be at least partially neutralised and can form salts ; (D1) 0-12 wt.% non-ionic hydrophilic chain extender, comprising at least one mono- or bifunctional ( relative to an isocyanate addition reaction) compound containing one or more hydrophilic polyether chains ; (E1) 0-15 wt.% one or more alcohols containing 2-4 hydroxyl groups and having molecular weights of 62-250 ; (F1) 0-15 wt.% one or more (cyclo)aliphatic polyamines containing 2-4 amino groups and having molecular weights of 60-300 ; (G1) 0-30 wt.% one or more (cyclo)aliphatic polyamine polyhydroxy compounds containing a total of 2-4 amino and hydroxyl groups and having molecular weights of 61-300 ; and (H1) 0-15 wt.% one or more mono- or bifunctional (relative to an isocyanate addition reaction) stabiliser component containing 1-2 hydrazide groups and having molecular weights of 70-300. Component (b) comprises : (A2) 40-80 wt.% polyisocyanate with an isocyanurate group content (calculated as C3N3O3 ; molecular weight = 26) of 2-30 wt.%, derived from diisocyanates molecular weights of 140-350 ; (B2) 5-30 wt.% one or more monofunctional (relative to an isocyanate addition reaction) capping agent for isocyanate groups ; (C2) 0-15 wt.% (potential) anionic chain extender comprising at least one compound containing one or more groups which can react with NCO groups and at least one group which may be at least partially neutralised and can form salts ; (D2) 5-30 wt.% non-ionic hydrophilic chain extender, comprising at least one mono- or bifunctional (relative to an isocyanate addition reaction) compound containing one or more hydrophilic polyether chains ; (E2) 0-15 wt.% one or more alcohols containing 2-4 hydroxyl groups and having molecular weights of 62-250 ; (F2) 0-15 wt.% one or more (cyclo)aliphatic polyamines containing 2-4 amino groups and having molecular weights of 60-300 ; and (G2) 0.5-15 wt.% one or more mono- or bifunctional (relative to an isocyanate addition reaction) stabiliser component containing 1-2 hydrazide groups and having molecular weights of 70-300. Also claimed is the preparation of these coating materials.
Patent JP-3203230-B2 (JP)
IPC: C07D491/107
Filed: 1998-05-06
Granted: 2001-08-27
Abstract: Piperidine compounds having the general general Formula Iwherein R<sup>1</sup> isa group having the general Formula II :wherein X is CHR<sup>10</sup>, O, S, SO, SO<sub>2</sub> or NR<sup>10</sup>, R<sup>10</sup> being hydrogen, alkyl or alkenyl, an amino group, sulfonyl, optionally substituted phenyl or a hetero aromatic group; Y is CH, CH<sub>2</sub>, NH, C=O or C=S; R<sup>a</sup> ― R<sup>d</sup> are substituents; U is CH<sub>2</sub>, O or S; Q<sup>1</sup> is a bond , alkylene or alkenylen and Q<sup>2</sup> alkylene having at least two C-atoms or alkenyleneR<sup>2</sup> and R<sup>3</sup> are hydrogen, or alkyl or they may together form an ethylene or propylene bridge; R<sup>4</sup> to R<sup>7</sup> are substituents; andZ<sup>1</sup> is substituent, Z<sup>2</sup> is hydrogen and Z<sup>3</sup> is (CH<sub>2</sub>)<sub>n</sub> wherein n is 0; show potent sigma receptor activity. Furthermore they show effect in animal models indicative of anxiolytic properties. Accordingly they are useful as medicines for the treatment of anxiety, psychosis, epilepsy, convulsion, movement disorders, motor disturbances, amnesia, cerebrovascular diseases, senile dementia of the Alzheimer type or Parkinson's disease.
Patent JP-H0569583-B2 (JP)
Inventor: PIITAA OOSEIIJIIMAA
IPC: C08F220/14
Filed: 1985-06-27
Abstract: Inert separator beads for separating cation exchange resins from anion exchange resins during regeneration of mixed-bed ion exchange resins are copolymers of 60 to 90 weight percent methyl methacrylate, 5 to 15 weight percent styrene and 2 to 10 weight percent hydrophilic monomer containing amide functionality, and 1 to 6 weight percent crosslinkiner. They may be made by suspension polymerisation or expanded seed polymerisation processes.
Patent JP-3023209-B2 (JP)
IPC: C21B7/00
Filed: 1991-04-04
Granted: 2000-03-21
Abstract: The device comprises an oblique portion connected by a gooseneck, a nozzle, atuyere and a ball-and-socket joint to the wall of the furnace, in which the oblique portion comprises a tapered tube flange-mounted by its upper part onto an upper connection piece forming part of a bustle pipe and the lower part of which dips axially into a lower connection piece integral with the gooseneck, a bellows expansion joint and tension rods ensuring the mechanical connection between the tapered tube and the lower connection piece. The lower connection piece and the tapered tube can move mutually in the axial direction and have means for limiting their radial mobility.
Patent JP-H0737475-B2 (JP)
IPC: C07H15/203
Filed: 1991-07-02
Abstract: Compound of the general formula 
<IMAGE>
 in which R represents CF3 or CN, and processes for their preparation and use as  beta -galactosidase substrate, in particular in a CEDIA system.
Patent JP-H0624546-B2 (JP)
IPC: A61B17/86
Filed: 1990-06-20
Abstract: An acetabular prosthesis assembly for implantation into a prepared acetabulum has a generally hemispherically-shaped cup (1). The cup (1) has a substantially hemispherically-shaped inner surface (2) and a substantially hemispherically-shaped outer surface (3) defining a wall therebetween. The wall has a plurality of generally circular apertures (6, 7, 8) therein for receiving a bone screw. The wall surrounding each aperture has a bevelled surface extending toward the outer surface (3) followed by a generally cylindrical surface extending from the bevelled surface to the outer surface of the cup. The generally cylindrical surface of each aperture (6, 7, 8) is threaded with threads of predetermined diameter and pitch. A bone screw has a first screw thread having a pitch and diameter for engagement with the thread of the cylindrical surface on the cup and a second screw thread having a major diameter and a pitch greater than the predetermined diameter and pitch of the cylindrical surface. A plastic insert for attachment to the inner surface of the cup is provided.
Patent JP-H0733042-B2 (JP)
IPC: B29C45/38
Filed: 1986-07-24
Abstract: An injection molded part of thermoplastic material, in particular an information carrier disk, is produced by cutting and removal of a sprue part from the injection molded part. The sprue removal leaves an opening in the injection molded part. In order to obtain a clean and smooth opening surface with a fit diameter that is as accurate as possible, the sprue part is axially offset relative to the injection molded part so that the integral connection between these two parts extends only over a part of the opening. The diameter of the axially projecting part is equal to or larger than the diameter of the opening and the rest of the opening being produced by injection molding. The dimensions are advantageously chosen so that a parting edge inclined at an angle of 45 DEG  to the plane of the opening is formed and that the injection molded part amounts to 70% and the part to be separated to 30% of the length of the opening. The injection molded length of the opening may also be variable. The sprue part may be cut from the injection molded part and removed, either in the closed or open state of the injection molding tool.
Patent JP-H08694-B2 (JP)
IPC: B01J21/04
Filed: 1989-07-26
Abstract: The present invention relates to a process for the manufacture of activated alumina agglomerates and to the agglomerates obtained according to this process. It relates more particularly to a process consisting in forming an alumina body by agglomerating an alumina powder obtained by a fast dehydration of an aluminium hydroxide, characterised in that it consists: (i) in aging these alumina bodies in an atmosphere with a controlled degree of humidity, (ii) in impregnating the aged bodies with a solution of one or more acids (iii) in subjecting these impregnated bodies to a hydrothermal treatment in a confined atmosphere, and (iv) in drying and calcining these bodies. The process of the invention makes it possible to preserve the pore distribution during the aging and autoclaving stages. The agglomerates of the invention are useful especially as supports for a catalyst or adsorbent.
Patent JP-3081288-B2 (JP)
IPC: G02B26/10
Filed: 1991-08-02
Granted: 2000-08-28
Abstract: A portable scanning head emits and receives light from a light-emitting diode (10) to read symbols, such as bar-code symbols. The optics (12,18) within the scanner are operative for focusing a light beam (11) and the view of a light sensor (17) in different planes (13,22) exteriorly of a scanner housing. Imaging means are provided in the unit for imaging a viewing window. The viewing window has an area smaller than that of the scan spot. The system can employ an LED (10) as a light source and tolerate the relatively large-sized (on the order of millimeters) scan spot without sacrificing reading performance since the photodiode (17) "sees" only that portion of the scan spot visible through the viewing window.
Patent JP-2761376-B2 (JP)
IPC: C12N15/49
Filed: 1996-08-20
Granted: 1998-06-04
Abstract: Purified material (I) contg. the polypeptide back bone of a glycoprotein of molecular wt. about 110,000, or antigen of lower molecular wt. derived from it, is new. (I) is recognised by sera of human origin and contg. antibodies against the virus of lymphadenopathies (LAV) or acquired immune deficiency syndrome (AIDS). Peptides corresp. to the aminoacid sequences deducible from proteins encoded by LAV DNA are new, when defined by specific residues, e.g. 12-32, 37-46, 49-79, 88-153 etc.
Patent JP-H0545561-B2 (JP)
Inventor: BERUNAA TETSUFURU
IPC: A01N25/32
Filed: 1983-12-03
Abstract: N-Sulfonyliminothiocarbonic acid diesters protect rice crops from phytotoxic damage caused by herbicides.
Patent JP-H07107380-B2 (JP)
IPC: F02M51/00
Filed: 1987-09-25
Abstract: The fuel injectors (4) of an internal combustion engine (2) are connected to a pump (10) by means of fuel supply lines (12) which open into the high-pressure part (34) of the injectors (4). The cross-sectional area of the fuel connection (12, 34) between the pump (10) and the injection orifices of the injectors (4) is substantially bigger than the total cross-sectional area of all of the injection orifices of an injector (4). An unrestricted flow path for the pressurized fuel is provided between the pump (10) and the area immediately upstream of the injection orifices. Due to the small pressurized volume of the system, the transient behaviour of the injection system is fast and can easily be matched to the needs of a particular engine application.
Patent JP-2800040-B2 (JP)
IPC: A61K36/16
Filed: 1989-09-20
Granted: 1998-09-21
Abstract: A process is provided for producing a purified extract from Ginkgo biloba leaves by solvent extraction with selected solvents. In the process, a crude or partially purified extract is subjected to solvent extraction with a solvent comprising a C6-8 aromatic hydrocarbon and a C3-6 lower alkanol. Pharmaceutical compositions comprising dimeric flavones and/or polyphenols are also described.
Patent JP-H0815749-B2 (JP)
IPC: B29C45/00
Filed: 1993-09-30
Abstract: The present invention relates to an apparatus for injecting molten plastic material. The apparatus includes a novel bushing arrangement (130) have a threaded portion which forms part of a mechanical connection between the bushing and an air piston housing (136) so as to reduce the possibility of plastic material leaking between the bushing and the air piston housing. The bushing has a melt channel (144) for mating with a melt channel (142) in a manifold (138) in which the bushing is housed and with an axial channel (120) in a nozzle body (112). The bushing is sized to fit within a bore (143) in the manifold so as to reduce the possibility of leakage between the bushing and the manifold. The bushing also serves to close off or plug holes or channels (162) drilled into the manifold. In one embodiment of the present invention, the bushing has a passageway through which a valve stem (126) for closing off a gate in the nozzle body passes. <IMAGE>
Patent JP-H0667841-B2 (JP)
IPC: A61K31/505
Filed: 1986-10-24
Abstract: Buspirone and its pharmaceutically acceptable salts are useful in alleviation of panic disorders which can take the form of clinical syndromes comprising, for example, panic attacks, agoraphobia and phobic anxiety.
Patent JP-3000067-B2 (JP)
IPC: A61N1/39
Filed: 1990-09-25
Granted: 2000-01-17
Abstract: An apparatus for defibrillating a mammal in need of defibrillation comprising:   a) a sensing means for determining the mammal's fibrillation cycle length; b) a shocking means for administering bursts of electrical current to a mammal; and c) a timing means, connected electrically to said sensing means and said shocking means, for activating said shocking means such that said means delivers a plurality of bursts of electrical current sequentially to said mammal, the timing between said bursts being based upon the fibrillation cycle length determined by said sensing means. p
Patent JP-3718267-B2 (JP)
IPC: G01N33/543
Filed: 1995-10-13
Granted: 2005-11-24
Abstract: In a method for performing heterogeneous immune reactions using a regenerable solid phase, the first specific binding partner (BP1) is directly, but reversibly, bound to the solid phase.
Patent JP-3049018-B2 (JP)
IPC: C07K16/00
Filed: 1998-09-24
Granted: 2000-06-05
Abstract: A variant HBsAg protein of fragment thereof displaying the antigenicity of Hepatitis B virus surface antigen is disclosed, in which the variant protein or fragment thereof (vHBsAg) comprises a modified a determinant in which there is an amino acid other than glycine at position 145 of the HBsAg sequence. A vaccine comprising the vHBsAg is provided, as it is a kit for diagnostic in vitro detection of anti-vHBsAg antibodies and an antibody preparation comprising anti-vHBsAg antibodies.
Patent JP-H0810633-B2 (JP)
IPC: H05H1/46
Filed: 1991-08-30
Abstract: A pair of dissimilarly-sized electrodes (84, 70) are driven by a radiofrequency source to create a plasma. A magnetic field (100) is oriented to be parallel to a surface area on the smaller electrode (84). The field strength increases to either side of that smaller electrode (84). As shown, ions are electrostatically accelerated out of the plasma, but they instead may be accelerated magnetically, electrons may in the alternative be extracted or there may be no accelerating mechanism. <IMAGE>
Patent JP-3038390-B2 (JP)
IPC: C10G67/06
Filed: 1988-12-28
Granted: 2000-05-08
Abstract: Process for elimination of mercury in hydrocarbon charges wherein said charge is contacted, under hydrogen, with a catalyst containing at least one metal from the group consisting of nickel, cobalt, iron and palladium followed by-or mixed with-a capture mass containing sulfur or a metal sulfide.
Patent JP-3713990-B2 (JP)
IPC: F16H63/50
Filed: 1998-12-15
Granted: 2005-11-09
Abstract: PROBLEM TO BE SOLVED: To enable returning the engine to running state and suppress, to the greatest extent possible, the state in which the engine is unable to recover to start even when the shift position is unable to be clearly identified, by structuring the control state so that it does not include the shift position in the return control conditions of the engine. SOLUTION: Output signals from various sensors and switches are input to an electronic control unit 47 such that when the stop conditions have been met in the N or P position, automatic stop control of an engine 1 is permitted, while the vehicle speed is 0, the foot brake switch is ON, an accelerator 15 is OFF, and the state of charge of the battery is at or above a predetermined level, the engine 1 automatically stops. Also, return control of the engine 1 is performed when either of the automatic stop conditions have not been met. In this way, automatic stop control of the engine 1 is performed only in the N or P position. Therefore, employing a control state in which return control is performed regardless of shift position improves the reliability of returning the engine to start.
Patent JP-3858545-B2 (JP)
IPC: H01L25/18
Filed: 1999-12-27
Granted: 2006-12-13
Abstract: PROBLEM TO BE SOLVED: To prevent a signal from being delayed by directly connecting a laminated semiconductor chip, without use of a wire for shorter conductive path. SOLUTION: After an electrode 16 is formed on a chip body surface 14, a vertical hole 24 is dug from a backside 22 of the chip body, until the electrode 16 is exposed. A metal wiring 30 is led out of a tungsten 18 and exposed in the vertical hole 24 to the backside 22 of chip main body. With this configuration for the semiconductor chip, the metal wiring 30 is drawn out, with the shortest distance from the surface 14, where the electrode 16 is formed to the backside 22 via the vertical hole 24. Other semiconductor chip, etc., is connected to the metal wiring 30 for the shortest connection to the electrode 16, so as to prevent a signal from being delayed.
Patent JP-3830520-B2 (JP)
IPC: A61P17/14
Filed: 1996-05-16
Granted: 2006-10-04
Abstract: The present invention relates to a relaxin-like factor, its derivatives or analogs, and uses thereof. The present invention further relates to compositions comprising a relaxin-like factor, its derivatives or analogs, and relaxin wherein such composition exhibits an additive or synergistic effect.
Patent JP-3577085-B2 (JP)
IPC: G01N33/58
Filed: 1996-05-23
Granted: 2004-10-13
Abstract: The present invention features an adduct protection assay involving the use of a labelled binding partner and a signal altering ligand. The signal altering ligand can preferentially alter the ability of label which is not part of a binding partner:analyte complex to produce a detectable signal, compared to its ability to alter signal produced from label which is part of a binding partner:analyte complex. The presence or amount of analyte can be determined by detecting the signal produced from unaltered label. The adduct protection assay is very versatile. For example, alteration of signal can be carried out under a wide range of conditions (e.g., pH, temperature, and ionic strength), and both label alteration and signal triggering can be carried out at essentially constant temperature to achieve a high degree of sensitivity. <IMAGE>
Patent JP-3313369-B2 (JP)
Inventor: CAUSTON BRIAN EDWARD
IPC: B05D7/14
Filed: 1994-05-26
Granted: 2002-08-12
Abstract: PCT No. PCT/US94/05925 Sec. 371 Date Feb. 6, 1996 Sec. 102(e) Date Feb. 6, 1996 PCT Filed May 26, 1994 PCT Pub. No. WO94/27744 PCT Pub. Date Dec. 8, 1994Disclosed is a method of coating cutting edges, more particularly razor blade cutting edges, with polytetrafluoroethylene (PTFE). The present method of forming a polytetrafluoroethylene (PTFE) coating on a razor blade cutting edge comprises: spraying the edge of an aqueous dispersion of PTFE having a molecular weight of at least 500,000 to form a coating of the PTFE of the cutting edge; subjecting the PTFE coating to ionizing radiation in the presence of an oxygen containing gas to obtain a radiation dose of up to 50 Mrads, and then sintering the PTFE coating.
Patent JP-H0831648-B2 (JP)
IPC: G02F2/00
Filed: 1987-01-27
Abstract: A method and apparatus for locking the frequencies of a number of first beams of coherent radiation from respective sources (17) are disclosed. Typically, the sources (17) will form local oscillators in respective transmitters (1). The apparatus comprises a reference beam generator (10) such as a HeNe laser which generates a primary reference beam fed to an interferometer (12) which generates a second, reference beam composed of a number of reference frequencies. This second reference beam is caused to interfere with each of the beams from the local sources (17) in an optical coupler (16) and the resultant beam is detected with a photodiode (22). The electrical output signal of the photodiode (22) is filtered and fed to a discriminator (25) which controls the frequency of the local laser (17). The discriminator (25) controls the laser (17) to maintain the relationship between the frequencies of the laser (17) and the reference laser (10) substantially constant.
Patent JP-3285361-B2 (JP)
IPC: A61P19/02
Filed: 1997-05-21
Granted: 2002-05-27
Abstract: PCT No. PCT/EP97/02577 Sec. 371 Date Nov. 24, 1998 Sec. 102(e) Date Nov. 24, 1998 PCT Filed May 21, 1997 PCT Pub. No. WO94/47577 PCT Pub. Date Dec. 18, 1997The present invention relates to colchicine and thiocolchicine derivatives which can be obtained from these molecules by functionalization of the C-7 to ketone or functionalization of the amino group. Said compounds have a marked antiblastic activity both on the normal cancer cells and on the chemoresistant phenotype. The compounds of the invention can be administered both by injection and orally.